用于治疗肝纤维化的过氧化酶修饰驱动的西利马林脂质体
Jijiao Wu1, Xing Liu1, Lin Wen1
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu university of Traditional Chinese Medicine, Chengdu, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Nanomedicine : nanotechnology, biology, and medicine
|August 21, 2025
概括
这项研究开发了用于治疗肝纤维化的催化酶 (CAT) 和西利马林 (SIL) 脂质体. 这种新疗法有效降低了小鼠的氧化应激和纤维化标志物.
科学领域:
- 生物化学
- 细胞生物学
- 药理学
背景情况:
- 肝纤维化涉及过度的细胞外基质沉积,并由氧化应激 (OS) 驱动.
- 反应性氧物种 (ROS) 激活肝星细胞并诱导肝损伤.
- 目前治疗肝纤维化的方法仍然有限.
研究的目的:
- 开发一种新的肝纤维化治疗方法,使用酶 (CAT) 和西利马林 (SIL).
- 研究CAT-SIL脂质体 (CAT-LP) 在减轻氧化应激和肝纤维化的有效性.
- 在临床前模型中评估CAT和SIL的协同效应.
主要方法:
- 使用催化剂 (CAT) 修饰携带氨酸 (SIL) 的脂质体的表面.
- 肝星细胞中细胞毒性,细胞吸收和ROS清除的体外评估.
- 在小鼠模型中评估肝纤维化标志物,氧化应激指标和原沉积.
主要成果:
- 通过CAT-LP检测显示细胞毒性较低,并被肝星细胞有效吸收,从而诱导细胞亡.
- 在富含H2O2的环境中,CAT-LP显著降低了ROS水平,并显示释放量有所增加.
- 在体内研究显示,马隆迪阿尔海德,转氨酶和III型公素水平降低,超氧化物脱酶增加.
结论:
- 在脂质体中结合CAT和SIL是治疗肝纤维化的有希望的策略.
- 它有效地抑制了ROS介导的损伤,并具有协同的肝保护作用.
- 这种方法为治疗慢性肝病和纤维化提供了新的治疗途径.
相关概念视频
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


